Baker Avenue Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-144
Closed -$811 791
2023
Q3
$811 Hold
144
﹤0.01% 1330
2023
Q2
$795 Buy
+144
New +$775 ﹤0.01% 1251
2023
Q1
Sell
-81
Closed -$377 1675
2022
Q4
$377 Buy
+81
New +$399 ﹤0.01% 1459

Other funds holding GDRX

Baker Avenue Asset Management's GDRX Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of GoodRx Holdings (GDRX) in Q4 2023, closing a stake of 144 shares — an estimated $811 sold.

Baker Avenue Asset Management first reported a position in GDRX in Q4 2022 and held it in 3 quarters. The position peaked at $811 in Q3 2023. 143 funds tracked by Wall St. Rank hold GDRX as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining GoodRx Holdings position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 144 GoodRx Holdings shares in Q4 2023, an estimated $811.
  • Baker Avenue Asset Management first reported a position in GoodRx Holdings in Q4 2022 and held it in 3 quarters.
  • Baker Avenue Asset Management's GoodRx Holdings position peaked at $811 in Q3 2023.
  • 143 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.